India, Oct. 21 -- Granules India has informed that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by the company for Fexofenadine Hydrochloride Tablets USP, 60 mg and 180 mg (OTC). It is bioequivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC. The above information is a part of company's filings submitted to BSE.

Published by HT Digital Content Services with permission from Accord Fintech....